Molecular Templates, Inc. Uncategorized Contracts & Agreements

40 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated CVR Agreement, dated February 20, 2025, by and among Molecular Templates, Inc., K2 HealthVentures LLC and Ankura Trust Company, LLC
Molecular Templates, Inc.
Biotechnology
2025
Sub-Sublease, dated May 12, 2024, by and between the Company and TracerDx
Molecular Templates, Inc.
Biotechnology
2024
Amended and Restated Non-Employee Director Compensation Policy, adopted by the Board of Directors of the Company on October 9, 2017, amended as of May 31, 2018 and further amended...
Molecular Templates, Inc.
Biotechnology
2024
Description of the Companys securities
Molecular Templates, Inc.
Biotechnology
2024
Molecular Templates, Inc. Clawback Policy
Molecular Templates, Inc.
Biotechnology
2023
Cancer Research Grant Contract, dated as of November 7, 2012, by and between the Cancer Prevention & Research Institute of Texas and Molecular Templates, Inc
Molecular Templates, Inc.
Biotechnology
TX
2018
Asset Transfer Agreement By and between Threshold Pharmaceuticals,Inc., A corporation organized and existing under thelaws of the State of Delaware, together with its successors...
Molecular Templates, Inc.
Biotechnology
2017
[Signature page follows]
Molecular Templates, Inc.
Biotechnology
2017
Portions of this Exhibit, indicated by the mark [***], were omitted and have been filed separately with the Secretary of theCommission pursuant to the Registrants application...
Molecular Templates, Inc.
Biotechnology
TX
2017
Form of Equity Commitment Letter by and between Registrant, Molecular Templates, Inc. and Longitude Venture Partners III, L.P., dated as of March 16, 2017
Molecular Templates, Inc.
Biotechnology
DE
2017
Lock-Up Agreement March 16, 2017
Molecular Templates, Inc.
Biotechnology
2017
Lock-Up Agreement March 16, 2017
Molecular Templates, Inc.
Biotechnology
2017
SUPPORTAGREEMENT
Molecular Templates, Inc.
Biotechnology
DE
2017
SUPPORT AGREEMENT
Molecular Templates, Inc.
Biotechnology
DE
2017
THIRD AMENDMENT TO RIGHTS AGREEMENT
Molecular Templates, Inc.
Biotechnology
2011
EXCLUSIVE LICENSEAGREEMENT
Molecular Templates, Inc.
Biotechnology
NY
2010
SECOND AMENDMENT TO RIGHTS AGREEMENT
Molecular Templates, Inc.
Biotechnology
2009
THRESHOLD PHARMACEUTICALS, INC.
Molecular Templates, Inc.
Biotechnology
2009
THRESHOLD PHARMACEUTICALS, INC. AMENDED AND RESTATED
Molecular Templates, Inc.
Biotechnology
CA
2008
AMENDMENT TO RIGHTS AGREEMENT
Molecular Templates, Inc.
Biotechnology
2008
FORM OF RIGHTS CERTIFICATE
Molecular Templates, Inc.
Biotechnology
2006
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
Molecular Templates, Inc.
Biotechnology
DE
2006
Shares
Molecular Templates, Inc.
Biotechnology
DE
2006
[6,250,000] Shares
Molecular Templates, Inc.
Biotechnology
NY
2005
2004 AMENDED AND RESTATED EQUITY INCENTIVEPLAN OF THRESHOLD PHARMACEUTICALS, INC.
Molecular Templates, Inc.
Biotechnology
DE
2005
THRESHOLD PHARMACEUTICALS, INC.
Molecular Templates, Inc.
Biotechnology
2005
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
Molecular Templates, Inc.
Biotechnology
CA
2005
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
Molecular Templates, Inc.
Biotechnology
DE
2005
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE
Molecular Templates, Inc.
Biotechnology
2005
2004 EMPLOYEE STOCKPURCHASE PLAN OF THRESHOLD PHARMACEUTICALS, INC. Table of Contents
Molecular Templates, Inc.
Biotechnology
DE
2005
Threshold Pharmaceuticals, Inc.
Molecular Templates, Inc.
Biotechnology
NY
2005
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
Molecular Templates, Inc.
Biotechnology
CA
2004
[LETTERHEAD OF THRESHOLD PHARMACEUTICALS, INC.]
Molecular Templates, Inc.
Biotechnology
2004
[LETTERHEAD OF THRESHOLD PHARMACEUTICALS, INC.]
Molecular Templates, Inc.
Biotechnology
2004
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
Molecular Templates, Inc.
Biotechnology
DE
2004
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED ANDFILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS...
Molecular Templates, Inc.
Biotechnology
CA
2004
THRESHOLD PHARMACEUTICALS, INC. And SILICON VALLEYBANK TABLE OF CONTENTS
Molecular Templates, Inc.
Biotechnology
CA
2004
*CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED ANDFILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS...
Molecular Templates, Inc.
Biotechnology
CA
2004
2004 EQUITY INCENTIVEPLAN OF THRESHOLD PHARMACEUTICALS, INC.
Molecular Templates, Inc.
Biotechnology
DE
2004
THRESHOLD PHARMACEUTICALS, INC.
Molecular Templates, Inc.
Biotechnology
DE
2004